- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-07-01-2020
Pharmaceutical Executive
Will COVID-19 Usher in a New Era in Pharma Marketing?
July 22, 2020
Columns
40
7
Embracing expanded digital models key to future ROI.
Is Drug Production Heading Back to Europe From Abroad?
July 09, 2020
Columns
40
7
Pandemic sparks call for European manufacturing renaissance.
Central Focus: Targeting Unmet Need in CNS
July 09, 2020
Features
40
7
Former physician and clinical researcher Antony Loebel, now president and CEO of Sunovion Pharmaceuticals, discusses his career-long mission to advance novel treatments for patients suffering from serious and underserved CNS disorders.
Will the Industry Rise to the Occasion?
July 09, 2020
From the Editor
40
7
Gilead's pricing of COVID drug remdesivir is a reminder of pharma's tenuous path forward as it seeks a more holistic image makeover.
How Oncologists are Coping with COVID-19
July 09, 2020
Columns
40
7
Report highlights how oncology practices are becoming more virtual-oriented in light of the global pandemic.
Virtual Hiring of the C-Suite
July 08, 2020
Columns
40
7
How COVID-19 has changed high-level recruitment.
Culture and Compliance: Building a Culture of Business Ethics
July 08, 2020
Features
40
7
Amid the limitations of traditional compliance programs that emphasize control measures, here are steps biopharma companies can implement in their own cultures to ensure they’re behaving and performing with integrity.
Fauci: Industry Will ‘Walk Away’ From COVID Price Controls
July 07, 2020
Columns
40
7
Stresses the need for fair pricing of therapies, while ensuring access.
A Sustainable Response to COVID-19
July 07, 2020
Columns
40
7
Three areas critical to ensuring meaningful long-term action.
Big Events Go Virtual: A Look Inside One Transformation
July 06, 2020
Columns
40
7
The transition from in-person was challenging, but meetings like DIA’s global event could explore formal hybrid models in the future.
Almirall and Digital Health: Skin in the Game
July 01, 2020
Columns
40
7
Accelerator program seeks to nourish promising innovation.
Enterprise Leadership: Is Compliance Ripe for Disruption?
July 01, 2020
Features
40
7
Case study illustrates how compliance teams, in today’s climate, can foster innovation across an organization to help achieve corporate goals.
Pharmaceutical Executive, July 2020 Issue (PDF)
July 01, 2020
Issue PDF
40
7
Click the title above to open the Pharmaceutical Executive July 2020 issue in an interactive PDF format.
The Pharma Supply Chain: Responding to COVID-19
July 01, 2020
Features
40
7
Taking stock of evolving practices in protecting the supply chain amid the pandemic, including partnering and planning for what’s next.
Leadership During Pandemic
July 01, 2020
Features
40
7
A recent roundtable moderated by Dr. Scott Gottlieb gathered biopharma CEOs to share thoughts and strategies on navigating their companies through the COVID-19 outbreak.